AI Breakthroughs Uncover Novel Targets for CAR T Cancer Therapy and Alzheimer's Disease
Penn Medicine and Insilico Medicine researchers harnessed AI algorithms to identify game-changing target antigens for CAR T oncology and Alzheimer's disease.
Philadelphia: Penn Medicine scientists deployed human-in-the-loop AI models to pinpoint protein target GPNMB, demonstrating robust tumor-clearing potency in CAR T cell therapies.
Concurrently, Insilico Medicine's PandaOmics AI uncovered five mitochondrial targets including ULK1 and OPA1 that halt neurodegenerative decline in Alzheimer's models.
About Biotech Desk
Biotech Desk is a senior correspondent at Greenline News covering health and related global events.
View all articles by Biotech DeskComments (2)
Excellent reporting on this issue. It's crucial that we stay informed about these developments.
I wonder how this will affect the local communities in the long run. Would love to see a follow-up article.